Fortress Biotech Inc FBIO:NASDAQ

Last Price$2.12NASDAQ Previous Close - Last Trade as of 3:57PM ET 1/26/22

Today's Change-0.14(6.19%)
Bid (Size)$1.84 (1)
Ask (Size)$2.98 (5)
Day Low / High$2.10 - 2.31
Volume381.1 K

View Biotechnology IndustryPeer Comparison as of 01/26/2022


Fortress Biotech Inc ( NASDAQ )

Price: $2.12
Change: -0.14 (6.19%)
Volume: 381.1 K
3:57PM ET 1/26/2022

Co-Diagnostics Inc ( NASDAQ )

Price: $6.93
Change: -0.28 (3.88%)
Volume: 570.7 K
3:57PM ET 1/26/2022

Aldeyra Therapeutics Inc ( NASDAQ )

Price: $3.42
Change: -0.09 (2.56%)
Volume: 1.1 M
3:57PM ET 1/26/2022

Epizyme Inc ( NASDAQ )

Price: $1.90
Change: -0.11 (5.47%)
Volume: 30.0 K
3:57PM ET 1/26/2022

Magenta Therapeutics Inc ( NASDAQ )

Price: $3.36
Change: +0.26 (8.39%)
Volume: 632.1 K
3:57PM ET 1/26/2022

Read more news Recent News

Fortress Biotech Starts Mid-Stage Triplex Vaccine Trial in Adults with HIV, Cytomegalovirus
10:56AM ET 12/16/2021 MT Newswires

Fortress Biotech (FBIO) on Thursday said that it has commenced a phase 2 trial to evaluate the safety, efficacy, and immunogenicity of Triplex in eliciting...

-- Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q3 EPS $0.54
4:03PM ET 11/15/2021 MT Newswires


-- Earnings Flash (FBIO) FORTRESS BIOTECH Reports Q3 Revenue $21.1M
4:01PM ET 11/15/2021 MT Newswires


Journey Medical Corp. Prices IPO at $10 Per Share
7:52AM ET 11/12/2021 MT Newswires

Journey Medical Corp., a subsidiary of Fortress Biotech (FBIO), on Friday priced its initial public offering of about 3.52 million common shares at $10...

View all Commentary and Analysis

Fortress Bio: Interesting Model Of Doing Medicine
7:19AM ET 4/29/2021 Seeking Alpha

Fortress Biotech (FBIO) Investor Presentation - Slideshow
12:59PM ET 3/26/2021 Seeking Alpha

Company Profile

Business DescriptionFortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the following Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded on June 28, 2006 and is headquartered in New York, NY. View company web site for more details
Address2 Gansevoort Street
New York, New York 10014
Number of Employees88
Recent SEC Filing12/07/20218-K
Chairman, President & Chief Executive OfficerLindsay Allan Rosenwald
Chief Financial Officer, Secretary & TreasurerRobyn M. Hunter
Senior Vice President-Biologics OperationsGeorge C. Avgerinos
Director & Vice Chairman-Strategic DevelopmentMichael Sean Weiss

Company Highlights

Price Open$2.27
Previous Close$2.12
52 Week Range$1.94 - 6.10
Market Capitalization$211.2 M
Shares Outstanding99.6 M
SectorHealth Technology
Next Earnings Announcement03/30/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.81
Beta vs. S&P 500N/A
Revenue$26.9 M
Net Profit Margin-59.80%
Return on Equity-37.76%

Analyst Ratings as of 02/25/2021

Consensus RecommendationConsensus Icon
Powered by Factset